Prof. Polina Stepensky Explains The CAR (Chimeric Antigen Receptor) T-Cell Therapy.

Hadasit, the Innovation Engine of Hadassah Medical Organization and BIRAD, the Commercialization arm of Bar-Ilan University announced today that they have entered into the research and license agreement with Immix BioPharma, for the development and commercialization of novel tissue specific therapeutics based on anti-BCMA CAR-T cells targeting plasma cell. This technology has been developed as the result of a collaboration between Prof. Polina Stepensky, of Hadassah Medical Center, Jerusalem and Prof. Cyrille J. Cohen, of Bar-Ilan University, Ramat Gan. Dr. Shlomit Kfir-Erenfeld and Dr. Nathalie Asherie, of Hadassah Medical Center, and Ortal Harush, of Bar-Ilan University, also participated in the research.

For more information visit Yahoo! Finance

Flooded with Thank You Letters

Weekly Story: Flooded with Thank You Letters

The Shamir Medical Centre (Assaf Harofeh) has been flooded with Thank You letters from patients and families affected by COVID-19. Read more for a letter to the hospital staff from Galia, a patient who was recently treated for a severe respiratory condition caused by COVID-19.

Hadassah Experts Advise Vienna Nursing Home on Vaccination Protocols

Weekly Story: Hadassah Experts Advise Vienna Nursing Home on Vaccination Protocols

On January 11, 2021, Hadassah Medical Center, along with Hadassah International, offered a webinar on optimum vaccination protocols for nursing home residents to the director and medical director of Maimonides Zentrum home for the aged, located in Vienna, Austria

Angels in White

Weekly Story: Angels in White

“Angles in White” were the words Israel’s Minister of Health, Yuli Edelstein, used to describe the dedicated medical team he met at Shamir Medical Centre (Assah Harofeh’s) Coronavirus Unit. As Israel deals with a 2nd wave of COVID-19, officials reached out to the hospital for insights and access to the critical work being done on the frontlines.

Can't Find What You're Looking For?